1. Imperiale, TF, Gruber, RN, Stump, TE, et al. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: A systematic review and meta-analysis. Ann Intern Med 2019; 170: 319–329.
Google Scholar | Crossref | Medline2. U.S. Preventive Services Task Force . Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 2021; 325: 1965–1977.
Google Scholar | Crossref | Medline3. Knudsen, AB, Rutter, CM, Peterse, EFP, et al. Colorectal cancer screening: An updated modeling study for the US preventive services task force. JAMA 2021; 325: 1998–2011.
Google Scholar | Crossref | Medline4. Fedewa, SA, Corley, DA, Jensen, CD, et al. Colorectal cancer screening initiation after age 50 years in an organized program. Am J Prev Med 2017; 53: 335–344.
Google Scholar | Crossref | Medline5. Jensen, CD, Corley, DA, Quinn, VP, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: A retrospective cohort study. Ann Intern Med 2016; 164: 456–463.
Google Scholar | Crossref | Medline | ISI6. Benito, L, Travier, N, Binefa, G, et al. Longitudinal adherence to immunochemical fecal occult blood testing vs guaiac-based FOBT in an organized colorectal cancer screening program. Cancer Prev Res 2019; 12: 327–334.
Google Scholar7. Chubak, J, Garcia, MP, Burnett-Hartman, AN, et al. Time to colonoscopy after positive fecal blood test in four U.S. Health care systems. Cancer Epidemiol Biomarkers Prev 2016; 25: 344–350.
Google Scholar | Crossref | Medline8. Tosteson, AN, Beaber, EF, Tiro, J, et al. Variation in screening abnormality rates and follow-up of breast, cervical and colorectal cancer screening within the PROSPR consortium. J Gen Intern Med 2016; 31: 372–379.
Google Scholar | Crossref | Medline9. Chubak, J, McLerran, D, Zheng, Y, et al. Receipt of colonoscopy following diagnosis of advanced adenomas: An analysis within integrated healthcare delivery systems. Cancer Epidemiol Biomarkers Prev 2019; 28: 91–98.
Google Scholar | Crossref | Medline10. van Heijningen, E-MB, Lansdorp-Vogelaar, I, Steyerberg, EW, et al. Adherence to surveillance guidelines after removal of colorectal adenomas: A large, community-based study. Gut 2015; 64: 1584–1592.
Google Scholar | Crossref | Medline | ISI11. Tae, CH, Moon, CM, Kim, S-E, et al. Risk factors of nonadherence to colonoscopy surveillance after polypectomy and its impact on clinical outcomes: A KASID multicenter study. J Gastroenterol 2017; 52: 809–817.
Google Scholar | Crossref | Medline12. Hoffmeister, M, Holleczek, B, Stock, C, et al. Utilization and determinants of follow–up colonoscopies within 6 years after screening colonoscopy: Prospective cohort study. Int J Cancer 2019; 144: 402–410.
Google Scholar | Crossref | Medline13. National Cancer Institute . Cancer intervention and surveillance modeling network (CISNET), http://cisnet.cancer.gov/ (accessed 23 September 2021).
Google Scholar14. Siegel, RL, Jemal, A, Ward, EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 1695–1698.
Google Scholar | Crossref | Medline | ISI15. Lin, JS, Perdue, LA, Henrikson, NB, et al. Screening for colorectal cancer: Updated evidence report and systematic review for the U.S. Preventive Services Task Force. JAMA 2021; 325: 1978–1997.
Google Scholar | Crossref | Medline16. Gupta, S, Lieberman, D, Anderson, JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: A consensus update by the US multi-society task force on colorectal cancer. Gastroenterology 2020; 158: 1131–1153.e1135.
Google Scholar | Crossref | Medline17. Bénard, F, Barkun, AN, Martel, M, et al. Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations. World J Gastroenterol 2018; 24: 124–138.
Google Scholar | Crossref | Medline18. de Jonge, L, Worthington, J, van Wifferen, F, et al. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: A comparative modelling study. Lancet Gastroenterol Hepatol 2021; 6: 304–314.
Google Scholar | Crossref | Medline19. Rutter, CM, Kim, JJ, Meester, RG, et al. Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: A modeling study. Cancer Epidemiol Biomarkers Prev 2018; 27: 158–164.
Google Scholar | Crossref | Medline20. Carolyn, M. Rutter, Jonathan, Ozik, Maria, DeYoreo, Nicholson, Collier, “Microsimulation model calibration using incremental mixture approximate Bayesian computation.” Ann. Appl. Stat 13(4): 2189–2212. December 2019. https://doi.org/10.1214/19-AOAS1279 (accessed 25 May 2021).
Google Scholar | Crossref21. Mutneja, H, Bhurwal, A, Arora, S, et al. A delay in colonoscopy after positive fecal tests leads to higher incidence of colorectal cancer: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021; 36: 1479–1486. DOI: 10.1111/jgh.15381.
Google Scholar | Crossref | Medline22. Corley, DA, Jensen, CD, Marks, AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014; 370: 1298–1306.
Google Scholar | Crossref | Medline | ISI23. Flugelman, AA, Stein, N, Segol, O, et al. Delayed colonoscopy following a positive fecal test result and cancer mortality. JNCI Cancer Spectrum 2019; 3: pkz024.
Google Scholar | Crossref | Medline24. Nayor, J, Saltzman, JR, Campbell, EJ, et al. Impact of physician compliance with colonoscopy surveillance guidelines on interval colorectal cancer. Gastrointest Endosc 2017; 85: 1263–1270.
Google Scholar | Crossref | Medline25. Burgess, DJ, Van Ryn, M, Grill, J, et al. Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med 2011; 26: 251–258.
Google Scholar | Crossref | Medline26. Liss, D, Baker, D. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: The contribution of socioeconomic status and access to care. Am J Prev Med 2014; 46: 228–236.
Google Scholar | Crossref | Medline27. Burnett-Hartman, AN, Mehta, SJ, Zheng, Y, et al. Racial/ethnic disparities in colorectal cancer screening across healthcare systems. Am J Prev Med 2016; 51: e107–e115.
Google Scholar | Crossref | Medline28. May, F, Yang, L, Corona, E, et al. Disparities in colorectal cancer screening in the united states before and after implementation of the affordable care act. Clin Gastroenterol Hepatol 2019; 18: 1796–1804.
Google Scholar | Crossref | Medline29. May, FP, Yano, EM, Provenzale, D, et al. Race, poverty, and mental health drive colorectal cancer screening disparities in the veterans health administration. Med Care 2019; 57: 773–780.
Google Scholar | Crossref | Medline30. Mojica, CM, Lind, B, Gu, Y, et al. Predictors of colorectal cancer screening modality among newly age-eligible medicaid enrollees. Am J Prev Med 2021; 60: 72–79.
Google Scholar | Crossref | Medline31. Warren Andersen, S, Blot, WJ, Lipworth, L, et al. Association of race and socioeconomic status with colorectal cancer screening, colorectal cancer risk, and mortality in southern US adults. JAMA Network Open 2019; 2: e1917995.
Google Scholar | Crossref | Medline32. Davis, MM, Renfro, S, Pham, R, et al. Geographic and population-level disparities in colorectal cancer testing: A multilevel analysis of medicaid and commercial claims data. Prev Med 2017; 101: 44–52.
Google Scholar | Crossref | Medline33. Moustaqim-Barrette, A, Spinelli, JJ, Kazanjian, A, et al. Impact on immigrant screening adherence with introduction of a population-based colon screening program in Ontario, Canada. Cancer Med 2019; 8: 1826–1834. DOI: 10.1002/cam4.2026.
Google Scholar | Crossref | Medline34. Patel, S, Kranick, J, Manne, S, et al. A population health equity approach reveals persisting disparities in colorectal cancer screening in New York City South Asian communities. J Cancer Educ 2021; 36: 804–810. DOI: 10.1007/s13187-020-01707-3.
Google Scholar | Crossref | Medline35. Rogers, CR, Obidike, OJ, Wallington, SF, et al. A qualitative study of barriers and enablers associated with colorectal cancer screening among Somali men in Minnesota. Ethn Health 2021; 26: 168–185.
Google Scholar | Crossref | Medline36. Dougherty, MK, Brenner, AT, Crockett, SD, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the united states: A systematic review and meta-analysis. JAMA Intern Med 2018; 178: 1645–1658.
Google Scholar | Crossref | Medline37. Miller, DP, Denizard-Thompson, N, Weaver, KE, et al. Effect of a digital health intervention on receipt of colorectal cancer screening in vulnerable patients. Ann Intern Med 2018; 168: 550.
Google Scholar | Crossref | Medline38. Christy, SM, Monahan, PO, Stump, TE, et al. Impact of tailored interventions on receipt of a preference-concordant colorectal cancer screening test. Med Decis Making 2020; 40: 29–41.
Google Scholar | SAGE Journals | ISI39. Partin, MR, Burgess, DJ, Burgess, JF, et al. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: An observational study. Cancer Epidemiol Biomarkers Prev 2015; 24: 422–434.
Google Scholar | Crossref | Medline